Article content

Neptune Wellness Solutions Inc. has entered into a multi-year, IP licensing and capsule sale agreement with life science company Lonza, thereby allowing Neptune to beef up capacity for producing cannabis oil in Canada.

The agreement will see Neptune’s customers “benefit from Lonza’s proprietary Licaps, liquid-filled, hard-capsule technology combined with Neptune’s leading extraction and purification capabilities, and significant capacity for the production of cannabis oil.”

We apologize, but this video has failed to load.

tap here to see other videos from our team. Try refreshing your browser, or Neptune sets sights on Canada’s cannabis oil capsule market with new licensing agreement Back to video

The new manufacturing line will be integrated into Neptune’s 50,000 sq ft cGMP facility in Sherbrooke, Que., notes a statement from the Laval, Que.-based health and wellness products company. Construction and installation of the new manufacturing line will begin immediately and represents an investment of about $2.5 million in IP transfer, know-how, site infrastructure and manufacturing equipment, Neptune reports.